Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
- Resource Type
- Article
- Source
- In
Diabetes Research and Clinical Practice August 2021 178 - Subject
- Language
- ISSN
- 0168-8227